Form PRE 14A Marker Therapeutics For: 10 March
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Marker Therapeutics Inc (MRKR)
Assess today's live Marker Therapeutics Inc (MRKR) share price, performance and insights using our live NASDAQ: MRKR stock exchange data.
Analyse the historical data and Marker Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Marker Therapeutics share price buy/sell indicators using real-time data (or discuss the Marker Therapeutics (MRKR) stock price today with other investors in the Marker Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ MRKR share price (ISIN: US57055L2060) to enhance your trading decisions with our free investment tools and resources.
What Is the Marker Therapeutics Inc Share Price Today?
The Marker Therapeutics share price today is 1.360.
What Is the Stock Symbol for Marker Therapeutics Inc
The stock symbol (or 'ticker') for Marker Therapeutics Inc is "MRKR."
What Stock Exchange Does Marker Therapeutics Inc Trade On?
Marker Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Marker Therapeutics Inc a Good Stock to Buy?
Determining whether Marker Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Marker Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Marker Therapeutics share price buy/sell indicators using real-time data (or discuss the Marker Therapeutics (MRKR) stock price today with other investors in the Marker Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ MRKR share price (ISIN: US57055L2060) to enhance your trading decisions with our free investment tools and resources.
What Is the Marker Therapeutics Inc Share Price Today?
The Marker Therapeutics share price today is 1.360.
What Is the Stock Symbol for Marker Therapeutics Inc
The stock symbol (or 'ticker') for Marker Therapeutics Inc is "MRKR."
What Stock Exchange Does Marker Therapeutics Inc Trade On?
Marker Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Marker Therapeutics Inc a Good Stock to Buy?
Determining whether Marker Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.360
1.426
52 wk Range
0.810
4.070
MRKR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.3601.426
52 wk Range
0.8104.070
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MRKR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
7.867
Upside
+478.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- Form 8K Marker Therapeutics Inc For: 9 February
- Investing.com
- Form PRE 14A Marker Therapeutics For: 10 March
- Investing.com
- Form 8K Marker Therapeutics Inc For: 9 February
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
Compare MRKR to Peers and Sector
Metrics to compare | MRKR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMRKRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.6x | −6.3x | −0.5x | |
PEG Ratio | 0.55 | −0.16 | 0.00 | |
Price/Book | 1.2x | 2.7x | 2.6x | |
Price / LTM Sales | 4.8x | 12.1x | 3.1x | |
Upside (Analyst Target) | - | 88.6% | 53.1% | |
Fair Value Upside | Unlock | 1.4% | 7.1% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.867
(+478.43% Upside)
Earnings
Latest Release
13/11/2025
EPS / Forecast
-0.12 / -0.62
Revenue / Forecast
1.23M / --
People Also Watch
FAQ
What Is the Marker Therapeutics (MRKR) Share Price Today?
The Marker Therapeutics stock price today is 1.360 USD.
What Stock Exchange Does Marker Therapeutics (MRKR) Trade On?
Marker Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Marker Therapeutics?
The stock symbol (also called a 'ticker') for Marker Therapeutics is "MRKR."
What Is the Current Marker Therapeutics Market Cap?
As of today, Marker Therapeutics market cap is 22.680M USD.
What Is Marker Therapeutics's (MRKR) Earnings Per Share (TTM)?
The Marker Therapeutics EPS is currently -1.120 (Trailing Twelve Months).
Is MRKR a Buy or Sell From a Technical Analyst Perspective?
Based on today's Marker Therapeutics moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Marker Therapeutics Stock Split?
Marker Therapeutics has split 5 times. (See the MRKR stock split history page for full effective split date and price information.)
How Many Employees Does Marker Therapeutics Have?
Marker Therapeutics has 5 employees.
What is the current trading status of Marker Therapeutics (MRKR)?
As of 18/03/2026, Marker Therapeutics (MRKR) is trading at a price of 1.360 USD, with a previous close of 1.360 USD. The stock has fluctuated within a day range of 1.360 USD to 1.426 USD, while its 52-week range spans from 0.810 USD to 4.070 USD.
What Is Marker Therapeutics (MRKR) Price Target According to Analysts?
The average 12-month price target for Marker Therapeutics is 7.867 USD, with a high estimate of 10 USD and a low estimate of 5.6 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +478.43% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.